HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
about
Prevalence of Hepatitis B Co-Infection among HIV Positive Patients: Narrative Review ArticleImpact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected childrHepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional studyImpact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIVHepatitis B and C viral infections among blood donors. A retrospective study from a rural community of Ghana.Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected GambiansDevelopment, coinfection, and the syndemics of pregnancy in Sub-Saharan AfricaHepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Sero-prevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV infection.The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi.Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemicAntiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource SettingsPrevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon?Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.Usefulness of a fourth generation ELISA assay for the reliable identification of HCV infection in HIV-positive adults from Gabon (Central Africa)HBV Infection Among HIV-Infected Cohort and HIV-Negative Hospital Attendees in South Western Nigeria.HIV, Hepatitis B, and Hepatitis C in Zambia.HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.Occult hepatitis B virus infection: A major concern in HIV-infected patients: Occult HBV in HIV.Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants.Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya.A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon.Sero-prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia.Intra-host diversity and evolution of hepatitis C virus endemic to Côte d'IvoirePrevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.High sero-prevalence of hepatitis B virus and human immunodeficiency virus infections among pregnant women attending antenatal clinic at Temeke municipal health facilities, Dar es Salaam, Tanzania: a cross sectional studyThe spectrum of cancers in West Africa: associations with human immunodeficiency virusEpidemiology and aetiology of maternal bacterial and viral infections in low- and middle-income countriesPrevalence of HIV and HCV infections in two populations of Malian women and serological assays performances.Hepatocellular cancer in HIV-infected individuals: tomorrow's problem?Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN studyShort-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infectionsPrevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa.Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis.Poor performance of hepatitis C antibody tests in hospital patients in Uganda.Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district.Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
P2860
Q26852495-4493CD2A-D8C9-46E5-862A-BB1D096D1A17Q33267065-B282DC23-49D9-4B9C-8141-B9BAF095339FQ33734612-25F58DBA-6525-4088-AD5D-05F65DA43813Q33748047-E1ACEB9F-6DA7-4C4A-A2A5-2CF5C544B3B3Q34094931-F7E1281C-1C49-454C-9BB4-3154CB14625CQ34174489-DCDBFF68-1566-4D2B-ABA9-1D258FE47173Q34254007-B073A76A-05C5-40AC-82A2-BE041F90D5A8Q34405008-365DCEE8-DF8C-47C9-8DA2-75FAEB573483Q34496866-05846D89-1C45-44F5-ABDC-56AF8807A6B8Q34523530-314603AE-21DE-40F5-ABB6-4E09421268DCQ34569072-578ABC49-B00B-4FC2-9DF0-9A3C42764341Q34730950-5B4504B8-0501-4B6C-A51B-8A25623AF3F9Q34908648-06A2E2DD-A29A-40DE-B559-E666BFEB466DQ34982182-A9A26CEC-2182-4AC9-B94E-F8E794C6B3E5Q35008964-B99AB8BF-6ADF-49B9-A39E-028FF32024F9Q35075700-D5125C74-D330-4DA3-8A41-C7AE9C39839DQ35183973-EC7C3425-440D-4F74-BB5D-BE884E404E3CQ35224111-BC8EA0AF-80F1-4ACD-B228-FCE615DE3337Q35507274-3E8F1B0C-EC66-4011-806B-D8A9E69410B7Q35542419-C7591B89-AE26-497A-80DA-F2A71153AF6DQ35661832-955FF0FA-338D-488C-B16D-0A559DEE38FFQ35861676-AE5DF441-89A9-4C4D-AF7A-0C38E47C9D33Q35932185-06EAA909-561F-4FAE-AEF0-2D37308F3A97Q36112861-EC368FB0-4214-4B65-BBAD-67BD8EF5981FQ36131256-5053AF92-8767-4DC3-B364-2D9BDF04A45FQ36340119-65343FA3-C20C-4C6A-A81A-1112B60DD5F0Q36353603-D09BA4EC-EBC2-4394-B91A-D2330F5CC31FQ36358973-D3830660-61C4-4755-BF7F-61374931EC04Q36561576-63919A86-5270-4172-80F5-769025F861F5Q36668229-EF24F26E-9905-432A-90E4-FE9C75A3EBECQ36839535-707D316C-9D34-4A3C-9949-A246AAB0FC1BQ36960592-067ECF4A-1D1B-498B-AAAE-016FA38FCBDEQ37047724-F0313FF7-6B6B-457D-92F1-51DC95123320Q37375386-522670DF-36D3-4519-880B-3FC7E6566148Q37503842-03CCF434-A283-46A0-89FB-E93BEAFDAE61Q38325427-E936E779-7931-4189-8030-2FC3DB8D322FQ38610365-A641126A-7FF0-460A-816C-F9289142BD93Q38872306-A487708B-8638-4C1E-8A96-1DE9743AED72Q39897671-72BE1E7D-0FFB-4D6B-897C-3DFBD73E3797Q40648463-60AF0E43-0366-4378-8398-AA3788648FCA
P2860
HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
HBV and HCV prevalence and vir ...... d'Ivoire: the ANRS 1236 study.
@en
HBV and HCV prevalence and vir ...... d'Ivoire: the ANRS 1236 study.
@nl
type
label
HBV and HCV prevalence and vir ...... d'Ivoire: the ANRS 1236 study.
@en
HBV and HCV prevalence and vir ...... d'Ivoire: the ANRS 1236 study.
@nl
prefLabel
HBV and HCV prevalence and vir ...... d'Ivoire: the ANRS 1236 study.
@en
HBV and HCV prevalence and vir ...... d'Ivoire: the ANRS 1236 study.
@nl
P2093
P2860
P50
P356
P1476
HBV and HCV prevalence and vir ...... d'Ivoire: the ANRS 1236 study.
@en
P2093
ANRS 1236 DITRAME-B&C Study Group
André Inwoley
François Rouet
Marie-Laure Chaix
Patrice Combe
Philippe Msellati
P2860
P356
10.1002/JMV.20143
P577
2004-09-01T00:00:00Z